PROF. DR. PETER VANGHELUWE

KU Leuven is a top ranked university and one of the most innovative universities in Europe and worldwide. At KU Leuven, I lead a dynamic and international research team with a focus on new cellular and lysosomal transport systems that are implicated in disease. Our molecular and cell biology research is highly innovative and collaborative in nature. Our findings fuel a drug discovery pipeline for heart failure, Parkinson's disease and other diseases, which run in partnership with the Center for Drug Design and Discovery at KU Leuven and major pharmaceutical companies.

 

Research of my team appeared in >50 publications in high impact journals such as Nature, PNAS, Brain and EMBO J.  Several of our research projects, awards and discoveries are covered in the videos and press releases.

 

Research is my passion, but I also enjoy hiking, dancing, running, traveling with my family, and of course great Belgian beer and chocolate!
 

Read more on my LinkedIn Page or website of the Department

We welcome international PhD students and postdocs: several projects are available.

We also welcome new research questions and collaborations: contact us if you want to test new disease links or mutations involving P-type ATPase genes, develop biochemical assays, screen for modulators of P-type ATPases.

You can contact me directly via peter.vangheluwe@kuleuven.be.

AWARDS

THE MICHAEL J. FOX FOUNDATION FOR PARKINSON’S RESEARCH AND THE SILVERSTEIN FOUNDATION AWARD

ERNEST SOLVAY PRIZE

JAKE’S RIDE FOR DYSTONIA RESEARCH AWARD

EMBO SHORT TERM FELLOWSHIP

THE MICHAEL J. FOX FOUNDATION FOR PARKINSON’S RESEARCH AND THE SILVERSTEIN FOUNDATION AWARD

FWO VASCULAR BIOLOGY SCHOLARSHIP AWARD

SYMPOSIUM AWARD OF THE SOCIETY OF GENERAL PHYSIOLOGISTS

KEYSTONE SYMPOSIA SCHOLARSHIP “MOLECULAR BIOLOGY OF CARDIAC DISEASE”

©2019 by Laboratory of Cellular Transport Systems.